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Background
A rapid, simple and affordable point-of care (POC) test
that can be implemented in peripheral health care settings
to replace/improve upon microscopy for TB diagnosis or
to rule out TB (triage) remains unmet.
Methods
Immunodominant regions of 3 Mycobacterium tuberculo-
sis specific cell–wall proteins that are highly immunogenic
in HIV- TB+ and HIV+TB+ patients have been mapped.
Antibodies to these regions are absent in subjects with
latent TB, BCG vaccination, other pulmonary diseases. To
examine the feasibility of devising a peptide based rapid
POC test, selected peptides were conjugated to a carrier
protein using standard EDC/NHS coupling chemistry,
purified by size exclusion; the peptide conjugation con-
firmed using MALDI MSMS before adsorption onto col-
loidal gold and striping onto nitrocellulose. The assay
parameters were adjusted to determine positive/negative
status within 15 minutes via visual or instrumented
assessment.
Results
The prototype POC test was evaluated with sera from
~400 TB patients, non TB subjects from the groups
defined in the methods section. The current prototype
POC test provides >90% sensitivity and specificity in the
above populations.
Conclusion
WHO recommends against use of all current commercial
serological TB tests since they fail to achieve adequate sen-
sitivity and specificity. These results demonstrate that, as
for HIV rapid tests, carefully selected immunodominant
epitopes of highly antigenic M. tuberculosis specific pro-
teins can be the basis of antibody detection based rapid
POC TB test. Test optimization to improve accuracy to
meet WHO specifications for a POC test to replace micro-
scopy or a triage test to rule-out TB are ongoing.
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